XML 13 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
BUSINESS COMBINATIONS AND ACQUISITIONS (Details 3) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Oct. 24, 2013
Optimer Pharmaceuticals, Inc.
Oct. 24, 2013
Optimer Pharmaceuticals, Inc.
DIFICID
Oct. 24, 2013
Optimer Pharmaceuticals, Inc.
Contract intangibles
Sep. 11, 2013
Trius Therapeutics, Inc.
Sep. 11, 2013
Trius Therapeutics, Inc.
DIFICID
Sep. 11, 2013
Trius Therapeutics, Inc.
Contract intangibles
Estimated fair values of the assets acquired and liabilities assumed                
Cash     $ 31,466     $ 22,697    
Investments     42,067     39,513    
Inventory     32,000     0    
IPR&D     0     659,000    
Intangible asset       561,000 36,000   0 0
Deferred tax assets     116,422     93,179    
Goodwill 381,930 381,930 108,360     159,440    
Other assets acquired     15,942     5,522    
Total assets acquired     943,257     979,351    
Deferred tax liabilities     (224,062)     (248,679)    
Other liabilities assumed     (34,109)     (30,359)    
Total liabilities assumed     (258,171)     (279,038)    
Total net assets acquired     $ 685,086     $ 700,313